South African Startup Scales Up Growth Factor for Low-Cost Cultivated Meat

Why It Matters

By lowering the price of a key media component, Immobazyme makes cultivated meat more economically viable, positioning South Africa as a regional leader in alternative protein manufacturing.

Key Takeaways

• Immobazyme scaled FGF‑2 production in a 50‑litre bioreactor
• Collaboration with CSIR reduces cultivated meat media costs
• Cost‑effective growth factor gives South Africa competitive edge globally
• Funding from DSTI and TIA supports biomanufacturing expansion
• Cultivated meat could aid Africa’s food security as population grows

Pulse Analysis

The cultivated‑meat sector has long grappled with the high cost of growth factors, which can account for up to 70% of cell‑culture media expenses. Immobazyme’s breakthrough—producing fibroblast growth factor 2 (FGF‑2) at scale in a 50‑litre bioreactor—directly tackles this bottleneck. By leveraging genetically engineered *E. coli* and a streamlined purification process, the startup delivers a protein powder that meets industry purity standards while slashing price points, a development that could reshape cost structures for cell‑based meat producers worldwide.

The success stems from a strategic alliance with South Africa’s Council for Scientific and Industrial Research (CSIR). Using the CSIR Biomanufacturing Industry Development Centre’s state‑of‑the‑art facilities, Immobazyme refined sterile fermentation, mechanical cell disruption, and centrifugation steps to harvest and purify FGF‑2 efficiently. Government backing from the Department of Science, Technology and Innovation and the Technology Innovation Agency provided the capital needed for this scale‑up, underscoring how public‑private partnerships can accelerate biotech innovation in emerging markets.

Beyond the technical win, the initiative has broader implications for the continent’s food security. Africa’s population is projected to near 2.5 billion by 2050, driving a surge in meat demand that traditional livestock systems struggle to meet sustainably. Affordable, locally produced cultivated‑meat inputs like Immobazyme’s FGF‑2 could enable home‑grown alternatives, reducing reliance on imports and mitigating environmental pressures. As more African startups enter the cell‑ag industry, this cost‑effective growth factor positions South Africa as a hub for scalable, low‑cost protein production, attracting investment and fostering a resilient, future‑proof food system.